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Background: Recurring dengue outbreaks occur in cyclical pattern in most endemic countries. The recurrences of
dengue virus (DENV) infection predispose the population to increased risk of contracting the severe forms of
dengue. Understanding the DENV evolutionary mechanism underlying the recurring dengue outbreaks has
important implications for epidemic prediction and disease control.
Results: We used a set of viral envelope (E) gene to reconstruct the phylogeny of DENV-1 isolated between the
periods of 1987–2011 in Malaysia. Phylogenetic analysis of DENV-1 E gene revealed that genotype I virus clade
replacements were associated with the cyclical pattern of major DENV-1 outbreaks in Malaysia. A total of 9
non-conservative amino acid substitutions in the DENV-1 E gene consensus were identified; 4 in domain I, 3 in
domain II and 2 in domain III. Selection pressure analyses did not reveal any positively selected codon site within
the full length E gene sequences (1485 nt, 495 codons). A total of 183 (mean dN/dS = 0.0413) negatively selected
sites were found within the Malaysian isolates; neither positive nor negative selection was noted for the remaining
312 codons. All the viruses were cross-neutralized by the respective patient sera suggesting no strong support for
immunological advantage of any of the amino acid substitutions.
Conclusion: DENV-1 clade replacement is associated with recurrences of major DENV-1 outbreaks in Malaysia. Our
findings are consistent with those of other studies that the DENV-1 clade replacement is a stochastic event
independent of positive selection.
Keywords: Infectious disease, Dengue, Immunity, Malaysia, Evolution, Clade replacementBackground
Dengue virus (DENV) is a virus of the Flaviviridae family.
It is an enveloped positive-sense single-stranded RNA
arbovirus with a genome of approximately 11 kb [1]. There
are four antigenically distinct DENV serotypes; DENV-1,
DENV-2, DENV-3 and DENV-4 [2] and each serotype
shows phylogenetically distinct genotypes [3]. The virus is
transmitted to susceptible hosts through bites of infected
mosquitoes. The virus is maintained in sylvatic nonhuman
primate/sylvatic mosquitoes and endemic human/urban/
peridomestic mosquitoes cycles. All four DENV serotypes
are believed to have independently evolved from separate
sylvatic ancestral lineages through either peridomestic/* Correspondence: sazaly@um.edu.my
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reproduction in any medium, provided the orurban mosquitoes or human hosts 100–1,500 years ago
[4]. Currently, an estimated 3.6 billion persons living in
dengue-endemic countries are at risk of contracting dengue.
The number of countries reporting dengue has in recent
years escalated to more than 125 suggesting successful
adaptation and dissemination of the virus [5].
In dengue endemic regions, heterotypic and homotypic
major dengue outbreaks occur in cyclical patterns of
approximately every 3–5 years and 7–10 years, respectively
[6-10]. The major concern associated with recurring
dengue outbreak in endemic countries is the risk of
contracting the severe forms of dengue especially following
second infection with a heterotypic virus [11]. Antibody-
dependent enhancement [12,13], original antigenic sin
[14,15], cytokine storm [16], and autoimmune responses
[17,18] are the possible mechanisms contributing to the
manifestation of severe dengue. It has been reported
that infection with one DENV serotype confers lifelongd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Teoh et al. BMC Evolutionary Biology 2013, 13:213 Page 2 of 10
http://www.biomedcentral.com/1471-2148/13/213protection against homotypic reinfection but only
temporary cross-protection against heterotypic infection
[19]. The presence of sub-neutralizing and cross-reacting
antibodies is suggested to play important role in the
manifestation of the severe dengue [20,21]. Reports of
repeated infection with dengue is however, not uncommon
in dengue endemic regions [22,23]. Understanding the
factors contributing to the recurrence of dengue outbreaks
has important implications for our understanding of
dengue epidemiology. Knowledge gained from this under-
standing could help improve dengue surveillance and
outbreak prediction and preparation. It could also help to
facilitate selection of better dengue vaccine candidates.
Earlier studies have suggested that DENV clade
replacement is linked to the recurring and cyclical
pattern of dengue outbreaks in many endemic countries
[6,24-27]. From these studies, it is suggested that clade
replacement is associated with positive selection due to
the differences in viral fitness between clades; new virus
with a higher viremia level in human [9] or enhanced
infectivity to mosquito [28-31] could be positively selected
to replace the old virus which was less fit. In contrary,
several other phylogenetic studies of DENV have suggested
that the clade replacement is solely a stochastic event due
to the virus population bottleneck effects [24,25]. Although
the potential mechanisms of DENV evolution underlying
the clade replacement have been investigated, correlation
studies involving the host immunological factors have not
been adequately addressed. Zhang et al. proposed that the
DENV-1 clade replacement is associated with the
cross-protective immunity accorded by DENV-4 based
on a longitudinal dengue epidemiological study in
Bangkok [6]. Whereas Adams et al. employed a mathemat-
ical model to demonstrate that the degree of interserotypic
cross-protective immunity could account for the cyclical
pattern of heterotypic outbreak in Bangkok [32].
In the present study, we used the recurring DENV-1
outbreaks in Malaysia which occurred in 1987, 1997
and 2004 [8,33], as a study model. The availability of
serially collected DENV-1 since 1987 within a single
locality (Klang Valley) provides us with an opportunity to
explore the temporal phylogenetic evolution that shapes
the virus clade replacement in recurring DENV-1 outbreaks
in Malaysia. We used DENV-1 full length envelope (E) gene
sequence to reconstruct the phylogeny and investigated the
presence of homotypic cross-neutralizing antibody of
patients with primary DENV-1 infection.
Results and discussion
In the study, a total of 335 Malaysian DENV-1 isolates
collected from 1987 to 2011 were used. All viruses were
isolated from dengue patients living in single locality,
Klang Valley. Between the periods, three major DENV-1
outbreaks occurred in 1987, 1997 and 2004 with a cyclicalpattern of ~8 years interval (Figure 1) [8,33]. Preliminary
phylogenetic analysis performed using the full E gene
sequence revealed that the virus collection comprised of
DENV-1 from genotype I, II, III and sylvatic group with
frequency of 80.6% (n = 270), 16.1% (n = 54), 3.0%
(n = 10) and 0.3% (n = 1), respectively (data not shown),
suggesting that DENV-1 outbreaks in Malaysia over the
last 3 decades were mainly caused by the genotype I and
II viruses. Figure 2 summarized the relative percentages of
DENV-1 genotypes isolated during the three major out-
breaks. Due to the large number of DENV-1 available for
each outbreak, the viral sequences with >98% nucleotide
identity within each monophyletic group were reduced to
3–6 sequences. A total of 44 representative isolates that
covered all possible viral genetic diversity over time were
presented in this study.
The Bayesian phylogenetic tree constructed using the
full E gene sequence (1485 nt) revealed the existence of
at least six distinct genotypes (Figure 3): three ancestral
genotypes (Japan/Hawaii 1943–1945, Thailand 1954–1964
and Malaysia/sylvatic 1972–2005) and three endemic/
epidemic genotypes (genotype I, II and III) in concordance
to the previous classification method [33,34]. DENV-1
genotype I viruses were involved in outbreaks in 1987,
1997 and 2004, while genotype II viruses were only
involved in the 1997 outbreak.
Genotype I comprised mainly of the Asian strains with
the exception of an African strain (D1.Djibouti/98). The
genotype I viruses from the 1987, 1997 and 2004 outbreaks
grouped into clade Ia, Ib and Ic, respectively in a
ladder-like topology (Figure 3) suggesting temporal
clade replacement occurred in each of the major
DENV-1 outbreak. All the genotype I clades consisted
of Thai viruses with approximately similar isolation
years (±7 years), suggesting that the same pool of
DENV-1 strains circulated within Thailand [6]. Viruses in
clade Ia and Ib shared clear ancestral lineages with Thai
isolates whereas those forming clade Ic could have
evolved from another Malaysian isolate seen in 1996
(D1.Malaysia.04834/96). The clade Ic viruses caused
the largest major DENV-1 outbreak in Malaysia in
2004 and the viruses shared high sequence similarity
to isolates recovered from a major outbreak in
Singapore in 2005 [35]. The clade Ic viruses were recov-
ered much earlier in Thailand (1997), China (1998),
Cambodia (2001), Vietnam (2002) and Myanmar (2002)
before it caused outbreak in Malaysia and Singapore.
Though all the clade Ic viruses shared common ancestral
lineage to the Malaysian 1996 isolate, it is possible that the
Malaysian 1996 virus was endemic in Malaysia but
remained in the background until it achieved fitness to
cause outbreak later in 2004 [33]. This fit the expected
homotypic cycle of major dengue outbreak in Malaysia at
approximately every 8 years. Since the 2004 outbreak,
Figure 1 DENV-1 isolated in Malaysia for the period 1967–2010. The number of DENV-1 isolated for the period 1975–1980 is not available.
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Singapore, Thailand, Vietnam, Cambodia and China until
2011 and no clade replacement event of DENV-1 was
observed then. The magnitude of 2004 outbreak involving
many Asian countries could probably extent the time
interval between the occurrences of major homotypic
DENV-1 outbreaks in the future. To date, the clade Ic
viruses have been imported into Japan (2001), South
Korea (2005), Taiwan (2008), Sri Lanka (2009), Indonesia
(2010) and Ireland (2010) [36-39] suggesting a possible
global spread of the virus to other parts of the world.
This could represent the most successful distribution
of DENV-1 to date akin to that observed for the
Cosmopolitan DENV-2 [40]. On the other hand, the
persistence of a ladder-like phylogenetic tree topology
predicts possible emergence of a clade Id DENV-1 in
the next major DENV-1 outbreak in Malaysia perhaps
in or around 2019.
The genotype II viruses obtained in the study shared
high sequence similarities to viruses from a wider
geographical distribution including Asia and PacificFigure 2 Distribution of DENV-1 genotypes in recurring DENV-1 outb
total numbers of DENV-1 used from each outbreak. Total numbers of DENV
period 1987–1989, 1997–1999 and 2004–2006, respectively.Ocean regions with the exception of an Indian Ocean
strain (D1.Seychelles.NIID41/03). In addition to clade Ib,
genotype II viruses (clade IIa and IIb) were also recovered
during the 1997 outbreak. Phylogenetic analysis suggests
that the clade IIa viruses could have evolved from another
Malaysian isolate seen in 1991 (D1.Malaysia.94946/91).
The clade IIa viruses are likely the indigenous DENV-1 of
Malaysia as no virus from other country was found within
the clade. In contrast, clade IIb viruses grouped with
isolates from Indonesia and South Pacific islands including
Micronesia and Polynesia. All the clade IIb viruses shared
common ancestral lineage to the Indonesia 1988 isolate.
The presence of the Indonesian isolates during the 1997
outbreak could be due to importation of the viruses
through influx of migrant workers as there was a surge of
workers from Indonesia to Malaysia during that time
[41]. In 2004, two isolates, D1.Malaysia.32858/04 and
D1.Malaysia.32581/04, which shared high sequence
similarities to the clade IIb viruses were recovered.
This could be either another incidence of importation
of the Indonesian isolate or an in situ evolution ofreaks in Malaysia. The numbers below the pie charts indicate the
-1 used for 1987, 1997 and 2004 outbreaks included viruses for the
Figure 3 (See legend on next page.)
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Figure 3 Maximum clade credibility tree of complete envelope genes of DENV-1. Horizontal branches are drawn to a scale of estimated
year of divergence. Coalescent times with 95% highest posterior density values (ranges in parentheses) and posterior probability values (all 1.0) of
key nodes are shown. DENV-1 outbreaks are indicated at the end of branches according to the outbreak-causing clades. The consensus E amino
acid sequences of Malaysian DENV-1 isolates used were indicated as Ia, Ib, Ic, IIa, IIb, IIIa and IIIb. The DENV-1 isolates from Malaysia are
highlighted in grey. Viruses marked with * are the rare isolates. A total of 39 new Malaysian DENV-1 E gene sequences were used
[EMBL:FN825674, EMBL:FR666920-FR666928].
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strains from the neighboring countries would increase
the genetic diversity of DENV-1 in Malaysia.
Genotype III consisted of mainly DENV-1 isolates
from Latin America. Asian and African strains of the
genotype III, however, have been occasionally isolated. The
genotype III viruses from Malaysia, D1.Malaysia.59266/87
and D1.Malaysia.11738/97, grouped with isolates from
Saudi Arabia, Brunei, India, Singapore and China and
shared common ancestral lineage to the Thai 1980 isolate.
In our samples, only 10 genotype III isolates (6 in 1987, 2
in 1995, 1 in 1996 and 1 in 1997) were recovered from
patients during the period 1987–1997. The virus has not
been isolated since 1998 which suggests its possible
extinction from Malaysia. Similar findings were observed
in Thailand and Myanmar in 1983 and 1998, respectively.
The lineage extinction of genotype III was hypothesized to
be due to a stochastic event attributable to possible low
rate of virus transmission during an inter-epidemic period
[6,42]. However, the emergence of genotype III virus in
Singapore in 2007 suggests possible reintroduction of
genotype III virus to Malaysia in the future [43].
Using the ancestral sylvatic virus E amino acid sequence
(D1.Malaysia.Sylvatic.P72_1244/72) as the basal sequence,
the consensus amino acid sequences of all the Malaysian
isolates were found highly conserved, with identities
ranging from 96 to 98% between the genotypes (Figure 4).
Although the genotype Japan/Hawaii 1943–1945 viruses
served as the common ancestral lineage for all the
genotype I viruses (Figure 3), the identities of consensus
amino acid sequences between sylvatic virus and genotype
I viruses were found to be higher (97%) than those
between the Japan/Hawaii 1943–1945 viruses and geno-
type I viruses (ranging from 95 to 97%) (data not shown).
Three conserved yet functionally important regions of
DENV-1 E were observed: the twelve disulfide bond-
forming cysteine residues; the glycine-rich fusion domain
(residues 98–111); and two glycosylated asparagines at
position Asn-67 and Asn-153 (data not shown) [44-46].
Out of 27 amino acid substitutions observed, only 9
(highlighted in grey) resulted in polarity changes
(non-conservative amino acid substitutions). These
non-conservative substitutions were found mostly in
domain I (residues 37, 52, 157 and 161), followed by
domain II (residues 88, 120 and 272) and domain III
(residues 305 and 369), suggesting that domain I maybe less functionally critical than domain II and domain III
[47]. The individual functional effect of each conservative
amino acid substitution may be unnoticeable or relatively
smaller than those of non-conservative substitutions,
but the cumulative effects of two or more neighboring
conservative substitutions at the three-dimensional space
could be important for the proper protein function.
In this study, we noted that the non-conservative amino
acid substitutions E120K (domain II) and G157E/D
(domain I) differentiated the three endemic genotypes
from the ancestral sylvatic group. Several other amino
acid substitutions gave rise to additional three endemic geno-
types (Figure 4). Within genotype I, two non-conservative
amino acid substitutions P305S (domain III) and N390S
(domain III) were identified in the 1997 viruses when
compared against the 1987 viruses. No non-conservative
amino acid substitution was observed between the viruses
from 1997 and 2004 outbreaks. The decreasing number of
amino acid substitution among the genotype I viruses
from 1987 to 2004 could suggest that the viruses may have
reached a point where all of the non-conservative amino
acid substitutions were deleterious.
Within genotype II, two non-conservative amino
acid substitutions D157E and T161I in domain I further
differentiated the viruses into the clade IIa and IIb. Tem-
poral analysis of amino acid substitution was not performed
for the clade IIa and IIb viruses due to their similar emer-
gence time during the 1997 outbreak. Whereas within
genotype III, two non-conservative amino acid substitutions
L305S (domain III) and M272T (domain II) were found be-
tween clade IIIa and IIIb. The M272T substitution located
at the “kl” β-hairpin region (residues 270 to 279). This “kl”
β-hairpin is a pH-dependent hinge region involved in the
fusion-activating conformational change [44]. Therefore,
any non-synonymous mutation in the “kl” β-hairpin region
could affect virus replication by altering the fusion pH
threshold resulting in inefficient virus replication [48,49].
This could help explain the rapid extinction of the genotype
III virus as the virus could not be efficiently propagated.
Selection pressure analyses of viral E gene collectively
found 183 (mean dN/dS = 0.0413), 136 (mean dN/dS =
0.0852), 245 (mean dN/dS = 0.0559) and 196 (mean dN/dS =
0.0704) negatively selected sites within the Malaysian isolates,
the genotype I, II and III isolates, respectively. No positively
selected codon site was noted within the Malaysian isolates
and within each of the genotypes. All observed amino acid
Table 1 Neutralization of DENV-1 from the different
cladesa using the respective DENV-1 patient serum
Virus clades
DENV-1 patient serumb Ia Ib Ic IIa IIb IIIa Sylvatic
Mockc 0 0 0 0 0 0 0
Ib 320 320 1280 80 80 80 320
Ic 320 80 320 80 320 320 320
IIa 320 80 320 80 80 80 80
IIb 80 320 320 80 80 80 320
a Neutralization titer was defined as an 80% reduction in the foci reduction
neutralization test (FRNT80).
b Serum sample from clade Ia is not available.
c Control treated with serum from healthy (no dengue infection) donors.
Figure 4 Observed amino acid substitutions in Malaysian DENV-1 E gene consensuses. The non-conservative amino acid substitutions
which resulted in the polarity changes are highlighted in grey. TM = Transmembrane.
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(Figure 4) were found to be under negative selection
except at the codon 8, 52, 161, 272, 339 and 390
which had no evidence of either negative or positive
selection but probably happened through neutral genetic
drift. Based on the Bayesian inference, the evolutionary
rates of DENV-1 E gene were estimated to be 3.39 × 10-4-
14.64 × 10-4 substitutions/site/year. The evolutionary rates
of DENV-1 E gene did not differ substantially from those
of other DENV serotypes (5.42 × 10-4-11.58 × 10-4 substi-
tutions/site/year) [50]. These rates, however, were rela-
tively lower than those of non-vector-borne RNA viruses
(~10-3 substitutions/site/year) such as influenza viruses
and HIV [51]. The DENV-1 evolution in Malaysia was
probably constrained by purifying selection [52].
The cross-neutralizing capacity of convalescent patient
serum samples from 1997 (Ib, IIa and IIb) and 2004 (Ic)
outbreaks were evaluated against viruses from seven clades:
Ia (D1.Malaysia.59280/87), Ib (D1.Malaysia.11177/97), Ic
(D1.Malaysia.36000/05), IIa (D1.Malaysia.11708/97), IIb
(D1.Malaysia.12796/97), IIIa (D1.Malaysia.59266/87) and
sylvatic group (D1.Malaysia.36046/05) (Table 1). The
neutralization titers of Ib sera against genotype I viruses
(FRNT80 = 320–1280) were higher than those of Ic,
IIa and IIb sera (FRNT80 = 80–320). All sera had
FRNT80 = 80 against genotype II and IIIa viruses except Ic
sera, which showed FRNT80 = 320 against the genotype
IIb and IIIa viruses. The neutralization titers of the IIa sera
against sylvatic virus (FRNT80 = 80) were lower than those
of Ib, Ic and IIb sera (FRNT80 = 320). Overall, all viruses
were neutralized by pooled sera from the 1997 and
2004 outbreaks with neutralization titers ranging from
FRNT80 = 80–1280. Interserotypic interaction of DENV-1
patient’s sera with other DENV serotypes, however, is not
available in this study to rule out any possible cross-
reactivity among them. Results presented here suggested
that there was no apparent immunological advantage
accorded by the new amino acid substitutions for the virusin countering the homotypic human herd immunity.
Therefore, the availability of a new susceptible human
population may be obligatory for DENV-1 to initiate a
new outbreak.
The human herd immunity developed after the DENV-1
outbreak could suppress the horizontal transmission of
virus to human population by infected mosquito [19]. This
could restrict the virus to continue to exist only in
mosquito population through vertical transmission [53,54].
The population dynamics of mosquito over time, however,
are mainly fluctuated by the stochastic environmental fac-
tors and the intermittent vector control measures [55,56].
This could repeatedly cause virus population bottlenecks
(small population size) which favor the amino acid substitu-
tions by genetic drift over those by natural selection [57].
Even if the positively selected substitutions are advan-
tageous, it could be randomly lost over time due to
the bottleneck effect. By contrast, the neutral substitutions
could be easily fixed in small virus population over time
by chance [58]. In our study, six codons with observed
amino acid substitutions in DENV-1 E gene consensuses
were under neutral genetic drift.
Our results suggest that the DENV-1 evolution in
recurring outbreak in Malaysia is likely to be a stochastic
Teoh et al. BMC Evolutionary Biology 2013, 13:213 Page 7 of 10
http://www.biomedcentral.com/1471-2148/13/213phenomenon, possibly driven by both negative selection
and genetic drift [6,24,25,52]. Whether the observed
amino acid substitutions would cause enhanced virus
replication in mosquito or human requires further
investigation. During the inter-epidemic period, the
increased viral fitness, however, may have no potential
epidemic impact due to the human herd immunity
that broadly cross-neutralized among different DENV-1
genotypes. Phylogenetic analysis in this study revealed that
the emergences of clade IIb (1997 outbreak) and clade Ic
viruses (2004 outbreak) were detected as early as in 1991
(D1.Malaysia.94946/91) and 1996 (D1.Malaysia.04834/96),
respectively. The reason why these viruses did not cause
outbreak when they were first encountered could be due
to the presence in the population of cross-neutralizing
immunity accorded by other DENV-1 genotypes. The
cyclical pattern of recurring DENV-1 outbreaks in Malaysia
suggests that a lag period of 7–10 years after the old
DENV-1 outbreak would be required for a newly evolved
virus to initiate another homotypic outbreak. During this
period, an increasing number of new susceptible human
hosts may gradually break down the human herd immunity
below the protective threshold, thus allowing the
restoration of virus horizontal transmission cycle in
human population. This suggests the possibility that it
is not always the fittest, but the fortuitous DENV-1
would be selected to be the clade replacement candi-
date which would initiate the next outbreak. And this
could occur when the ecological situation favors the
virus transmission. The appearances of rare isolates
such as D1.Malaysia.92844/91, D1.Malaysia.10837/97,
D1.Malaysia.32581/04, D1.Malaysia.32858/04 and D1.
Malaysia.296236/11 (Figure 3, marked with *) could repre-
sent the potential clade replacement candidates for the
future major outbreaks.
The present study is limited by working only with
the viral E gene, such that evolutionary pressures on
other gene regions will be missed. Also, during the
inter-epidemic periods between the homotypic outbreaks,
the available sample set selected for sequencing is limited.
This leaves gaps in understanding the extinction and emer-
gence of the different clades. Thirdly, the interserotypic
interaction between the DENV-1 with other co-circulating
virus serotypes is not addressed in this study. This is
important as the interserotypic immune reaction could
account for the alternating epidemic pattern of DENV
serotypes in endemic regions. The cross-neutralization
assay in this study is within the limitation where the
possible cross-reactivity between different DENV sero-
types was not examined. This was due to the unavailability
of sufficient convalescent sera from dengue patients since
the study was using retrospectively collected sera. As such
further studies which will include early convalescent
serum from DENV-2, DENV-3 or DENV-4 infection isdesirable. Another limitation of the present study is that
the immune responses of patients were averaged in the
pooled sera; the neutralizing capacity of each serum
might vary depending on the time of blood collection
and genetic background of patients. Notwithstanding
the limitation of the study, findings from the study
provide opportunities to understand the possible mecha-
nisms driving to cyclical pattern of major dengue outbreaks
in endemic regions.
Conclusions
DENV-1 clade replacement is associated with the recur-
ring major DENV-1 outbreaks in Malaysia. Our findings
from selection pressure analyses and neutralization assays
are consistent with earlier studies [24,25] suggesting that




The DENV-1 isolates used in this study were isolated from
Klang Valley during the period of time spanning 25 years
(1987–2011). Almost all the isolates came from patients
who seeked medical treatment at the University Malaya
Medical Centre (UMMC), a major referral hospital serving
an estimated of 8.1 million people, mostly living within
25 km of the hospital. All the viruses were archived at the
UMMC Diagnostic Virology Laboratory. The isolates at
passage 1 were used to inoculate C6/36 (Aedes albopictus)
mosquito cells for one week and virus RNA was extracted
from this infected cell culture supernatant.
RNA extraction, RT-PCR and nucleotide sequencing
Viral RNA was extracted using QIAamp Viral RNA Mini
Kit (Qiagen, Germany) strictly following the manufacturer’s
instructions. One-step RT-PCR was performed to amplify
DENV-1 E gene using the primers as previously described
[34]. The amplified DNA fragments were purified using
QIAquick Gel Extraction Kit (Qiagen, Germany) and
sequenced using the BigDye Terminator v3.1 Cycle
Sequencing Kit on an automated capillary DNA sequencer
3730xl DNA Analyzer (Applied Biosystems, USA).
Phylogenetic analysis
The DENV-1 E gene dataset for phylogenetic analysis
comprised of 44 isolates from Malaysia and 121 global
sequences representing the 6 distinct DENV-1 genotypes as
previously reported [33,34]. The maximum clade credibility
tree (MCC) was inferred by using the Bayesian Markov
Chain Monte Carlo (MCMC) method implemented in
BEAST version 1.6.2 [59]. The best-fit model of nu-
cleotide substitution was selected by Akaike Information
Criterion (AIC) and Bayesian Information Criterion (BIC)
as implemented in jModelTest 0.1.1 [60]. Both AIC and
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best-fit model for the dataset. Two independent MCMC
analyses (100 million steps) were performed utilizing
relaxed uncorrelated lognormal molecular clock with
Bayesian skyline as coalescent prior. The convergence of
the chain was evaluated by using Tracer 1.5 [59]. The
effective sample size (ESS) values of >200 indicated
sufficient level of sampling. The MCC tree was generated
and visualized by using TreeAnnotator program and
FigTree 1.2.3, respectively. The degree of uncertainty in
each parameter estimate is provided by the 95% highest
posterior density (HPD) values.Selection pressure analysis
The selection pressure analysis was performed by
using the online facility of Datamonkey web server
(http://www.datamonkey.org) based on the neighbor
joining tree [61]. Four datasets were included, one
containing only Malaysian isolates (n = 44) and the
other three containing isolates belonged to the three
different virus groups, genotype I (n = 63), genotype II
(n = 36) and genotype III (n = 57). Five likelihood-
based algorithms: SLAC, FEL, IFEL, REL and PARRIS
methods were used to identify the existence of positive
selection pressure at individual codon sites in the DENV-1
E gene. Sites were considered to be under positive selec-
tion if the ratio of non-synonymous (dN) to synonymous
(dS) substitutions per site (ratio dN/dS) indicated with
high statistical significance (P <0.1 / Bayes factor >50).Patient sera
The study obtained ethics approval from the UMMC
Medical Ethics Committee (Ethics Committee/IRB
Reference Number: 860.24 and 908.9). Paired (acute
and convalescent) DENV-1 patient serum samples
from 1997 (Ib, IIa and IIb) and 2004 (Ic) outbreaks
were obtained from UMMC Diagnostic Virology
Laboratory. Informed consents were not obtained
from the patients as this study was using retrospectively
collected sera. The acute and convalescent serum samples
were taken at a mean of 4.3 days (range, 1–6 days) and
12.5 days (range, 5–24 days) post-onset, respectively. Acute
DENV-1 infection was confirmed by virus isolation and a
seroconversion of anti-DENV IgM in paired serum sam-
ples. Serum samples with optical density (OD) absorbance
value ≥2.0 in the in-house IgM capture enzyme-linked im-
munosorbent assay (ELISA) were detected as IgM-positive
sera [62]. Serum samples were classified as either primary
or secondary infection sera using the hemagglutination
inhibition (HI) test [63]. Convalescent serum samples with
an HI titer <1:1280 were classified as primary infection
sera, whilst those with an HI titer ≥1:2560 were classified
as secondary infection sera [64].Foci reduction neutralization test (FRNT)
Serum of convalescing dengue patient with primary
infection with the respective DENV-1 genotype I and
genotype II were used to determine their cross-neutralizing
capacities against viruses from other subgroups. Due to the
very limited amount of serum, serum samples (2–3 serum
samples) from each of the different genotype group were
pooled. The pooled serum was heat-inactivated at 56°C for
30 min and diluted four-fold (1:10 to 1:10240) in FBS-free
EMEM medium. Serum samples (100 μl) were incu-
bated with 100 FFU of virus (100 μl) at 37°C for 1 h.
Subsequently, the mixtures (200 μl) were transferred to the
C6/36 cell monolayer in 24-well plate and incubated at
room temperature for 1 h. The mixtures were replaced with
overlay EMEM medium [supplemented with 2% FBS and
1.5% carboxymethylcellulose (CMC)] and the plate was
incubated at 28°C for 4 days. Foci of infected cells were
visualized by using peroxidase-based foci staining assay as
described previously [62,65]. The neutralizing antibody titer
was expressed as the maximum serum dilution yielding
80% reduction in foci formed (FRNT80).
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